Bradley J. Bolzon PhD

Insider Reports History

Location
San Francisco, CA
Signature
/s/ Elizabeth Ryland Waldinger, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Bradley J. Bolzon PhD:

Company Role Class Num Shares Value Price $ Report Date Ownership
Monte Rosa Therapeutics, Inc. Director, 10%+ Owner Common Stock 6,799,115 $129,183,185 $19.00 28 Jun 2021 By Versant Venture Capital VI, L.P.
Monte Rosa Therapeutics, Inc. Director, 10%+ Owner Common Stock 2,097,938 $39,860,822 $19.00 28 Jun 2021 By Versant Vantage I, L.P.
CRISPR Therapeutics AG Director Common Shares 148,831 $9,302,369 $62.50 19 Jul 2021 Indirect
Monte Rosa Therapeutics, Inc. Director, 10%+ Owner Stock Option (Right to Buy) 47,132 23 Jun 2021 Direct
Black Diamond Therapeutics, Inc. Director, 10%+ Owner Stock Option (Right to Buy) 15,000 18 Jun 2021 Direct
CRISPR Therapeutics AG Director Stock Option (Right to Buy) 12,000 09 Jun 2022 Direct
Monte Rosa Therapeutics, Inc. Director, 10%+ Owner Series A convertible preferred stock 0 28 Jun 2021 By Versant Capital VI, L.P.
Monte Rosa Therapeutics, Inc. Director, 10%+ Owner Series B convertible preferred stock 0 $2.00 28 Jun 2021 By Versant Capital VI, L.P.
Monte Rosa Therapeutics, Inc. Director, 10%+ Owner Series B convertible preferred stock 0 $2.00 28 Jun 2021 By Versant Vantage I, L.P.
Monte Rosa Therapeutics, Inc. Director, 10%+ Owner Series C convertible preferred stock 0 $2.96 28 Jun 2021 By Versant Vantage I, L.P.

Insider Reports Filed by Bradley J. Bolzon PhD

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CRSP CRISPR Therapeutics AG 09 Jun 2022 1 $0 4 Director 10 Jun 2022, 17:35
CRSP CRISPR Therapeutics AG 19 Jul 2021 4 -$1,264,348 4 Director 21 Jul 2021, 17:21
CRSP CRISPR Therapeutics AG 28 Jun 2021 25 -$7,106,341 4 Director 30 Jun 2021, 18:41
CRSP CRISPR Therapeutics AG 28 Jun 2021 14 -$4,631,583 4 Director 30 Jun 2021, 18:38
GLUE Monte Rosa Therapeutics, Inc. 28 Jun 2021 7 +$3,000,005 4 Director, 10%+ Owner 30 Jun 2021, 17:05
GLUE Monte Rosa Therapeutics, Inc. 23 Jun 2021 0 $0 3 Director, 10%+ Owner 23 Jun 2021, 20:47
BDTX Black Diamond Therapeutics, Inc. 18 Jun 2021 1 $0 4 Director, 10%+ Owner 22 Jun 2021, 18:12
CRSP CRISPR Therapeutics AG 11 Jun 2021 5 -$1,266,118 4 Director 15 Jun 2021, 16:41
CRSP CRISPR Therapeutics AG 10 Jun 2021 1 $0 4 Director 14 Jun 2021, 17:36
GLUE Monte Rosa Therapeutics, Inc. 24 Feb 2021 4 +$15,149,998 4 Director, 10%+ Owner 25 Jun 2021, 17:00